Search results
Found 10672 matches for
Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.
Molecular Diagnostics Centre
An ISO-accredited research facility specialising in the next generation sequencing of liquid biopsies
MCHUGH GROUP
Studying DNA damage and repair to understand the causes of cancer and improve its treatment.
SIBSON GROUP
Experimental Neuroimaging
FAIRFAX GROUP
Genomics of Inflammation and Cancer Immunology
TARSOUNAS GROUP
Genome Stability and Tumourigenesis
GLEESON GROUP
Novel Clinical Imaging Research
SCHUH GROUP
Oxford Molecular Diagnostics
VALLIS GROUP
Experimental Radiotherapeutics
HAMMOND GROUP
Tumour Hypoxia
HIGGINS GROUP
Tumour Radiosensitivity
Mechanical Workshop
The Mechanical Workshop delivers an on-site fabrication facility for custom-made, precision mechanical items for use in scientific research.
Microscopy
The Microscopy SRF aims to provide research groups with imaging technologies to investigate cellular processes both in vitro and in vivo.
Radiation Biophysics
The Radiation Biophysics Facility develops and supports a unique range of radiation resources and techniques along with providing associated expertise.
KERR GROUP
Adjuvant Colorectal Cancer
SEYMOUR GROUP
Anticancer Viruses and Cancer Vaccines
BODMER GROUP
Cancer and Immunogenetics
LA THANGUE GROUP
Cancer Cell Cycle
BLAGDEN GROUP
Cancer Therapeutics and mRNA Dysregulation